Molecular Templates Inc (MTEM)

[Digra Ive]

Phase 3 - Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma (MAESTRO)
All relevant info is here ( Pay attent., datis are estimated )
https://clinicaltrials.gov/show/NCT01746979
Enrollment: 694
Study Start Date: December 2012
Estimated Study Completion Date: February 2017
Estimated Primary Completion Date: February 2016
Final data collection date for primary outcome measure)